Beat Therapeutics

Redefining the fight against aggressive cancers with innovative therapies

Big Idea

BEAT Therapeutics is a biotech company founded in 2023 with an unwavering commitment to transforming cancer treatment. We are dedicated to developing innovative therapies to fight aggressive cancers characterized by treatment resistance and limited effective therapeutic options. Our lead drug candidate targets pancreatic cancer as a clinical priority and, is a first-in-class small molecule that inhibits a crucial pathway in the DNA repair of cancer cells, demonstrating high therapeutic efficacy in preclinical assays.


Ângela Carvalho, Co-founder & COO; Hugo Prazeres, Co-founder & CEO.


  • Young Entrepreneur Award 2023, ANJE
  • 1st place iUP25k and UI.CAN competition
  • 1st place Startup Olé pitch competition (Bio/pharma tech category)
  • 2nd place – EIT Health InnoStars Grand Final

Investment Manager Portugal Ventures

Pedro Grilo